Ketamine: Clinical Uses and Dosing Guidelines
Primary Medical Applications
Ketamine serves three FDA-approved and guideline-supported roles: general anesthesia induction and maintenance, acute perioperative pain management as an opioid-sparing agent, and treatment-resistant depression (esketamine formulation). 1
Anesthesia
- Induction dosing: 1-4.5 mg/kg IV (average 2 mg/kg produces 5-10 minutes of surgical anesthesia within 30 seconds) or 9-13 mg/kg IM (produces surgical anesthesia within 3-4 minutes lasting 12-25 minutes) 1
- Maintenance: Repeat half to full induction dose as needed, or continuous infusion at 0.1-0.5 mg/minute 1
- Administer IV doses slowly over 60 seconds to prevent respiratory depression and enhanced vasopressor response 1
- Critical advantage: Maintains cardiovascular stability through central NMDA blockade and preserved adrenal function, making it superior to propofol or dexmedetomidine in shock states 2, 3
- Produces bronchodilation, making it the agent of choice for patients with life-threatening asthma or acute bronchial constriction 4
Acute Pain Management
For perioperative pain, use sub-anesthetic doses of 0.5 mg/kg IV bolus followed by 1-2 μg/kg/min infusion, which reduces opioid requirements by approximately 22 mg morphine equivalents without increasing side effects. 2
Specific Dosing Protocols:
- Intraoperative: Maximum 0.5 mg/kg/h after anesthesia induction, with continuous infusion at 0.125-0.25 mg/kg/h; discontinue 30 minutes before end of surgery and administer longer-acting opioid to prevent analgesic gap 2, 5
- ICU setting: 0.5-2 mg/kg/hr continuous infusion (maximum 100 mg/hour), using lowest effective dose 2
- Pediatric patients: 0.5 mg/kg as adjunct to intraoperative opioids, with optional continuous infusion of 0.1-0.2 mg/kg/hr (maximum 0.4 mg/kg/hr) 2
- Breakthrough pain in PACU: 0.5 mg/kg titrated to effect 2
Route-Specific Efficacy:
- Local infiltration (particularly peritonsillar) consistently demonstrates superior analgesia compared to IV administration and effectively reduces pain and analgesic requirements 6
- Subcutaneous administration provides similar analgesia to IV route 6
- Intramuscular route lacks analgesic efficacy 6
- Oral administration is less effective than infiltration 6
Specialized Pain Applications
- Cancer-related neuropathic pain: IV ketamine recommended when other modalities fail, though data suggest only modest analgesic potential for opioid-refractory cancer pain 2
- ICU patients with refractory pain: Ketamine helps prevent or reduce opioid tolerance and provides relief when pain is unresponsive to opioids and other agents 6
- Pre-operative administration provides better pain relief than postoperative dosing 6
Critical Safety Considerations
Monitoring Requirements
When administering ketamine for procedural sedation, provide care consistent with general anesthesia standards, including ability to identify and rescue patients from unintended deep sedation. 5
- Maintain vascular access throughout procedure until patient is no longer at risk for cardiorespiratory depression 5
- Continuous cardiac monitoring and pulse oximetry during infusion 2
- Regular assessment of sedation level, respiratory status, and hemodynamics 2, 5
Side Effects Management
- Emergence reactions (postoperative confusional states, agitation, vivid imagery, hallucinations) occur in approximately 12% of patients 1
- Psychotomimetic effects (dysphoria, nightmares, hallucinations) occur especially at higher doses; co-administration with benzodiazepines minimizes these effects 6, 2, 1
- Administer benzodiazepine during induction and maintenance to prevent neuropsychological manifestations during emergence 1
- Minimize verbal, tactile, and visual stimulation during recovery period 1
- Sedation was the predominant side effect in multiple studies 6
- Continuation of ketamine into postoperative period increases hallucination risk without significantly enhancing analgesia 5
Absolute Contraindications
- Uncontrolled cardiovascular disease (contraindicated when significant blood pressure elevation would constitute serious hazard) 2, 5, 1
- Pregnancy 2, 5
- Active psychosis 5
- Severe liver dysfunction 5
- High intracranial or ocular pressure 5
- Known hypersensitivity to ketamine or excipients 1
Special Populations
Patients with Hemodynamic Instability
- Ketamine maintains cardiovascular stability better than alternatives, but can still suppress myocardial contractility in patients with depleted catecholamine reserves 3
- Start at lower end of dosing range (0.5 mg/kg IV bolus) and titrate carefully in significant hemodynamic compromise 3
- Monitor for transient increases in blood pressure, heart rate, and cardiac index, as well as potential decreases in blood pressure, arrhythmias, and cardiac decompensation 1
Pediatric Procedural Sedation
- Combination of ketamine and midazolam shows fewer complications compared to midazolam/meperidine regimens 5
- 88% of pediatric patients successfully sedated at initial doses of 1 mg/kg or less 5
Preparation and Administration
- Do not inject 100 mg/mL concentration IV without proper dilution 1
- For induction: Dilute with equal volume of Sterile Water, Normal Saline, or 5% Dextrose; use immediately after dilution 1
- For maintenance infusion: Add 10 mL from 50 mg/mL vial or 5 mL from 100 mg/mL vial to 500 mL of 5% Dextrose or Normal Saline to create 1 mg/mL solution 1
- When fluid restriction required: Add to 250 mL infusion to provide 2 mg/mL concentration 1
- Inspect for particulate matter and discoloration before administration; discard if present 1
Key Clinical Pearls
- Avoid mixed agonist-antagonists (butorphanol, pentazocine) in combination with ketamine 2
- Strong evidence supports IV ketamine in perioperative period to reduce opioid use in first 24 hours after hip and knee arthroplasty 5
- Purposeless and tonic-clonic movements of extremities may occur during ketamine anesthesia; these do not indicate light anesthesia plane or need for additional doses 1
- Ketamine provides analgesia while reducing opioid requirements, potentially beneficial in patients with gastritis at risk for opioid-induced gastrointestinal side effects 3